Transactivation_NN
of_IN
the_DT
interleukin-1alpha_NN
promoter_NN
by_IN
human_JJ
T-cell_NN
leukemia_NN
virus_NN
type_NN
I_CD
and_CC
type_NN
II_CD
Tax_NN
proteins_NNS
._.

Human_JJ
T-cell_NN
leukemia_NN
virus_NN
type_NN
I_CD
-LRB-_-LRB-
HTLV-I_NN
-RRB-_-RRB-
-_:
infected_JJ
T-cell_NN
lines_NNS
constitutively_RB
produce_VBP
high_JJ
levels_NNS
of_IN
interleukin-1alpha_NN
-LRB-_-LRB-
IL-1alpha_NN
-RRB-_-RRB-
._.

To_TO
analyze_VB
the_DT
mechanisms_NNS
that_WDT
lead_VBP
to_TO
the_DT
expression_NN
of_IN
IL-1alpha_NN
in_IN
HTLV-I-infected_JJ
cell_NN
lines_NNS
,_,
we_PRP
studied_VBD
regulatory_JJ
regions_NNS
of_IN
the_DT
human_JJ
IL-1alpha_NN
promoter_NN
involved_VBN
in_IN
activation_NN
of_IN
the_DT
IL-1alpha_NN
gene_NN
._.

IL-1alpha_NN
promoter_NN
constructs_NNS
drive_VBP
transcription_NN
of_IN
the_DT
chloramphenicol_NN
acetyltransferase_NN
-LRB-_-LRB-
CAT_NN
-RRB-_-RRB-
reporter_NN
gene_NN
in_IN
HTLV-I-positive_JJ
MT-2_NN
cells_NNS
,_,
which_WDT
constitutively_RB
produce_VB
IL-1alpha_NN
._.

In_IN
a_DT
cotransfection_NN
assay_NN
,_,
the_DT
Tax_NN
protein_NN
of_IN
both_CC
HTLV-I_NN
and_CC
HTLV-II_NN
specifically_RB
activated_VBD
transcription_NN
from_IN
the_DT
IL-1alpha_NN
promoter_NN
in_IN
an_DT
uninfected_JJ
Jurkat_NN
cell_NN
line_NN
._.

A_DT
mutant_JJ
Tax_NN
protein_NN
deficient_JJ
in_IN
transactivation_NN
of_IN
genes_NNS
by_IN
the_DT
nuclear_JJ
factor_NN
-LRB-_-LRB-
NF_NN
-RRB-_-RRB-
-_:
kappaB_NN
pathway_NN
was_VBD
unable_JJ
to_TO
induce_VB
transcriptional_JJ
activity_NN
of_IN
IL-1alpha_NN
promoter-CAT_JJ
constructs_NNS
,_,
but_CC
was_VBD
rescued_VBN
by_IN
exogenous_JJ
provision_NN
of_IN
p65\/p50_NN
NF-kappaB_NN
._.

We_PRP
found_VBD
that_IN
two_CD
IL-1alpha_NN
kappaB-like_JJ
sites_NNS
-LRB-_-LRB-
positions_NNS
-1,065_CD
to_TO
-1,056_CD
and_CC
+646_CD
to_TO
+655_CD
-RRB-_-RRB-
specifically_RB
formed_VBD
a_DT
complex_NN
with_IN
NF-kappaB-containing_JJ
nuclear_JJ
extract_NN
from_IN
MT-2_NN
cells_NNS
and_CC
that_IN
NF-kappaB_NN
bound_VBD
with_IN
higher_JJR
affinity_NN
to_TO
the_DT
3_CD
'_``
NF-kappaB_NN
binding_NN
site_NN
than_IN
to_TO
the_DT
5_CD
'_''
NF-kappaB_NN
site_NN
._.

Moreover_RB
,_,
deletion_NN
of_IN
either_CC
5_CD
'_NN
or_CC
3_CD
'_NN
NF-kappaB_NN
sites_NNS
reduced_VBD
IL-1alpha_NN
promoter_NN
activity_NN
in_IN
MT-2_NN
cells_NNS
and_CC
transactivation_NN
of_IN
the_DT
IL-1alpha_NN
promoter_NN
by_IN
exogenous_JJ
NF-kappaB_NN
and_CC
Tax_NN
in_IN
Jurkat_NN
cells_NNS
._.

These_DT
data_NNS
suggest_VBP
a_DT
general_JJ
role_NN
for_IN
Tax_NN
induction_NN
of_IN
IL-1alpha_NN
gene_NN
transcription_NN
by_IN
the_DT
NF-kappaB_NN
pathway_NN
._.

Expression_NN
of_IN
IL-1alpha_NN
by_IN
HTLV-I_NN
productively_RB
infected_JJ
cells_NNS
may_MD
be_VB
important_JJ
in_IN
the_DT
hypercalcemia_NN
,_,
osteolytic_JJ
bone_NN
lesions_NNS
,_,
neutrophilia_NN
,_,
elevation_NN
of_IN
C-reactive_JJ
protein_NN
,_,
and_CC
fever_NN
frequently_RB
seen_VBN
in_IN
patients_NNS
with_IN
HTLV-I-induced_JJ
adult_JJ
T-cell_NN
leukemia\/lymphoma_NN
._.

